99 related articles for article (PubMed ID: 17645670)
1. Polymeric photosensitizer prodrugs for photodynamic therapy.
Campo MA; Gabriel D; Kucera P; Gurny R; Lange N
Photochem Photobiol; 2007; 83(4):958-65. PubMed ID: 17645670
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis.
Gabriel D; Busso N; So A; van den Bergh H; Gurny R; Lange N
J Control Release; 2009 Sep; 138(3):225-34. PubMed ID: 19445983
[TBL] [Abstract][Full Text] [Related]
3. Enhanced prostate cancer targeting by modified protease sensitive photosensitizer prodrugs.
Zuluaga MF; Gabriel D; Lange N
Mol Pharm; 2012 Jun; 9(6):1570-9. PubMed ID: 22548315
[TBL] [Abstract][Full Text] [Related]
4. Thrombin-sensitive dual fluorescence imaging and therapeutic agent for detection and treatment of synovial inflammation in murine rheumatoid arthritis.
Gabriel D; Lange N; Chobaz-Peclat V; Zuluaga MF; Gurny R; van den Bergh H; Busso N
J Control Release; 2012 Oct; 163(2):178-86. PubMed ID: 22959919
[TBL] [Abstract][Full Text] [Related]
5. Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes.
Gabriel D; Campo MA; Gurny R; Lange N
Bioconjug Chem; 2007; 18(4):1070-7. PubMed ID: 17477499
[TBL] [Abstract][Full Text] [Related]
6. Using the singlet oxygen scavenging property of carotenoid in photodynamic molecular beacons to minimize photodamage to non-targeted cells.
Chen J; Jarvi M; Lo PC; Stefflova K; Wilson BC; Zheng G
Photochem Photobiol Sci; 2007 Dec; 6(12):1311-7. PubMed ID: 18046487
[TBL] [Abstract][Full Text] [Related]
7. Strategies for enhanced photodynamic therapy effects.
Verma S; Watt GM; Mai Z; Hasan T
Photochem Photobiol; 2007; 83(5):996-1005. PubMed ID: 17880492
[TBL] [Abstract][Full Text] [Related]
8. Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer.
Suci PA; Varpness Z; Gillitzer E; Douglas T; Young M
Langmuir; 2007 Nov; 23(24):12280-6. PubMed ID: 17949022
[TBL] [Abstract][Full Text] [Related]
9. Bis(3,5-diiodo-2,4,6-trihydroxyphenyl)squaraine: a novel candidate in photodynamic therapy for skin cancer models in vivo.
Gayathri Devi D; Cibin TR; Ramaiah D; Abraham A
J Photochem Photobiol B; 2008 Sep; 92(3):153-9. PubMed ID: 18653354
[TBL] [Abstract][Full Text] [Related]
10. Conjugation of a photosensitizer to an oligoarginine-based cell-penetrating peptide increases the efficacy of photodynamic therapy.
Choi Y; McCarthy JR; Weissleder R; Tung CH
ChemMedChem; 2006 Apr; 1(4):458-63. PubMed ID: 16892381
[TBL] [Abstract][Full Text] [Related]
11. Initiation of apoptosis by photodynamic therapy using a novel positively charged and water-soluble near infra-red photosensitizer and white light irradiation.
Schastak S; Yafai Y; Geyer W; Kostenich G; Orenstein A; Wiedemann P
Methods Find Exp Clin Pharmacol; 2008; 30(1):17-23. PubMed ID: 18389094
[TBL] [Abstract][Full Text] [Related]
12. Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice.
Lee SJ; Park K; Oh YK; Kwon SH; Her S; Kim IS; Choi K; Lee SJ; Kim H; Lee SG; Kim K; Kwon IC
Biomaterials; 2009 May; 30(15):2929-39. PubMed ID: 19254811
[TBL] [Abstract][Full Text] [Related]
13. Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection.
O'Riordan K; Akilov OE; Chang SK; Foley JW; Hasan T
Photochem Photobiol Sci; 2007 Oct; 6(10):1117-23. PubMed ID: 17914486
[TBL] [Abstract][Full Text] [Related]
14. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
[TBL] [Abstract][Full Text] [Related]
15. A tumor mRNA-triggered photodynamic molecular beacon based on oligonucleotide hairpin control of singlet oxygen production.
Chen J; Lovell JF; Lo PC; Stefflova K; Niedre M; Wilson BC; Zheng G
Photochem Photobiol Sci; 2008 Jul; 7(7):775-81. PubMed ID: 18597024
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic and sonodynamic treatment by phthalocyanine on cancer cell lines.
Kolarova H; Tomankova K; Bajgar R; Kolar P; Kubinek R
Ultrasound Med Biol; 2009 Aug; 35(8):1397-404. PubMed ID: 19515482
[TBL] [Abstract][Full Text] [Related]
17. Response surface methodology: an extensive potential to optimize in vivo photodynamic therapy conditions.
Tirand L; Bastogne T; Bechet D; Linder M; Thomas N; Frochot C; Guillemin F; Barberi-Heyob M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):244-52. PubMed ID: 19604651
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for corneal neovascularization using polymeric micelles encapsulating dendrimer porphyrins.
Sugisaki K; Usui T; Nishiyama N; Jang WD; Yanagi Y; Yamagami S; Amano S; Kataoka K
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):894-9. PubMed ID: 18326709
[TBL] [Abstract][Full Text] [Related]
19. Comparison of photodynamic therapy with phthalocyanine and photofrin in human colorectal carcinoma.
Stukavec J; Horak L; Duchac V; Jirasek T; Rakusan J; Karaskova M; Pouckova P
Neoplasma; 2008; 55(2):127-9. PubMed ID: 18237250
[TBL] [Abstract][Full Text] [Related]
20. Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy.
Bae BC; Na K
Biomaterials; 2010 Aug; 31(24):6325-35. PubMed ID: 20493523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
